Recombinant Human Interleukin-2/IL-2 Protein (E.coli, Active)

The Recombinant Human Interleukin-2/IL-2 Protein (E.coli, Active) is a highly purified and bioactive protein that is produced using advanced recombinant DNA technology. This protein is derived from E.coli bacteria and is designed to mimic the natural human Interleukin-2 (IL-2) protein, which plays a crucial role in regulating the immune system.

This product is manufactured under strict quality control measures to ensure its purity, potency, and consistency. It is produced in a state-of-the-art facility using a highly efficient expression system, resulting in a high yield of active protein. The recombinant IL-2 protein is then purified using advanced chromatographic techniques, removing any impurities and contaminants, to provide a product of exceptional quality.

The Recombinant Human Interleukin-2/IL-2 Protein (E.coli, Active) is widely used in various research applications, including immunology, cancer research, and vaccine development. It can be used to stimulate the growth and proliferation of T cells, B cells, and natural killer cells, thereby enhancing the immune response. Additionally, this protein can be utilized to study the mechanisms of immune regulation and to investigate the potential therapeutic applications in various diseases.

In summary, the Recombinant Human Interleukin-2/IL-2 Protein (E.coli, Active) is a highly purified and bioactive protein that is produced using advanced recombinant DNA technology. It is manufactured under strict quality control measures and is widely used in research applications related to immunology and cancer research. With its exceptional purity and potency, this protein offers researchers a valuable tool to study immune regulation and explore potential therapeutic applications.